Subscribe to eTOC

Estrogen-Modulating Therapies Associated with Lower Risk of Dementia in Breast Cancer Patients

Neurology Today At the American Academy of Neurology Annual Meeting: Women with breast cancer who were taking tamoxifen and steroidal aromatase inhibitors had a decreased risk for a neurogenerative disease, specifically Alzheimer's disease and dementia. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews Gregory Branigan, a graduate student researcher at the University of Arizona College of Medicine, about the clinical implications of the research. Read the full report with Neurology Today At the Meetings: https://bit.ly/3sye70E.


Recent Videos

Show: